CTI BioPharma Corp Banner Image

CTI BioPharma Corp

  • Ticker CTIC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
CTI BioPharma Corp Logo Image
  • 201-500 Employees
  • Based in Seattle, Washington
CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative for the treatment of adult patients with multiply relapsed or refractory aggressive B-cellMore non-Hodgkin lymphoma in the European Union.
4.7 / 5.0 (155)

CTI BioPharma Corp reports have an aggregate usefulness score of 4.7 based on 155 reviews.

CTI BioPharma Corp

Most Recent Annual Report

CTI BioPharma Corp
MOST RECENT 2022 Annual Report and Form 10K

CTI BioPharma Corp does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

CTI BioPharma Corp Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!